| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |